SOMATULINE DEPOT INJECTION
Cipla gets USFDA nod to market Lanreotide injectionCipla has received approval from the US FDA to market its Lanreotide injection, a generic medication for treating acromegaly and other cond...
Sun, Cipla and Gland remain top pharma picks in 2022: Nithya Balasubramanian“In terms of the sector, I would say it is back to basics. I would not recommend a pure Covid play at all.“
Cipla gains 3% on USFDA nod to market Lanreotide"This approval is a significant step for our US business and is in line with our aspiration to continue growth in our complex product pipel...
Cipla receives USFDA nod to market Lanreotide injection in American marketThe company said it has received final approval for Lanreotide Injection from the US Food and Drug Administration (USFDA). The FDA approval...
Load More